Title

Inhaled aztreonam

UMMS Affiliation

Department of Pediatrics

Publication Date

2010-05-01

Document Type

Article

Subjects

Administration, Inhalation; Anti-Bacterial Agents; use; Aztreonam; Cystic Fibrosis; Drug Discovery; Humans; Lysine; Pseudomonas Infections; Pseudomonas aeruginosa; Treatment Outcome

Disciplines

Allergy and Immunology | Pediatrics | Respiratory Tract Diseases

Abstract

In February 2010, aztreonam for inhalation solution (Cayston; Gilead) - an inhalable formulation of the monobactam antibiotic aztreonam and lysine - was approved by the US FDA to improve respiratory symptoms in patients with cystic fibrosis infected with Pseudomonas aeruginosa.

DOI of Published Version

10.1038/nrd3170

Source

Nat Rev Drug Discov. 2010 May;9(5):357-8. Link to article on publisher's site

Journal/Book/Conference Title

Nature reviews. Drug discovery

Related Resources

Link to Article in PubMed

PubMed ID

20431562

Share

COinS